Determinants of fructosamine levels in a multi-ethnic Sub-Saharan African population

Diabetes Research and Clinical Practice

Volumn 107, Issue 1, 2015, Pages 123-129

  Nouya, Audrey Yondjeu ^a   Nansseu, Jobert Richie N ^b,c   Moor, Vicky Joceline Ama ^c,d   Pieme, Constant Anatole ^c   Noubiap, Jean Jacques N ^e   Tchoula, Corinne M ^c   Mokette, Bruno M ^c   Takam, Ruth Danielle M ^a   Tankeu, Francine ^c   Ngogang, Jeanne Yonkeu ^c,d   Kengne, Andre Pascal ^c,f  

^a Higher Institute of Public Health Sciences   (Cameroon)

^b Sickle Cell Unit Mother and Child Centre Chantal Biya Foundation ^*  (Cameroon)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d University Teaching Hospital Yaounde   (Cameroon)

^e Internal Medicine Unit Edea Regional Hospital   (Cameroon)

^f SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Cameroon; Correlates; Fructosamine; Sub Saharan Africa

Indexed keywords

BILIRUBIN; FRUCTOSAMINE; GLUCOSE; BLOOD GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED;

AFRICAN; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CAMEROON; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; ETHNICITY; HUMAN; HYPERBILIRUBINEMIA; MEDICAL HISTORY; OUTCOME ASSESSMENT; SEX DIFFERENCE; URBAN AREA; ADULT; AFRICA SOUTH OF THE SAHARA; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANALYSIS; BLOOD; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; ETHNOLOGY; FASTING; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; URBAN POPULATION;

ADULT; AFRICA SOUTH OF THE SAHARA; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BLOOD GLUCOSE; CAMEROON; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ETHNIC GROUPS; FASTING; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; URBAN POPULATION;

EID: 84922832766     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.09.042     Document Type: Article

References (32)

1. The Diabetes Control and Complications Trial (DCCT) Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
2. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853.
3. Tahara Y., Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995, 18(4):440-447.
4. Paroni R., Ceriotti F., Galanello R., Battista Leoni G., Panico A., Scurati E., et al. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem 2007, 40(18):1398-1405.
5. Dafallah A.A., Eskandarani H., Rehaimi A., Al-Ali A.K., Elbashir A.M., Saba R. Fructosamine in HbS and G6PD-deficient Saudi Arabs in the Eastern Province of Saudi Arabia. Br J Biomed Sci 1994 Dec, 51(4):332-335.
6. Koga M., Hashimoto K., Murai J., Saito H., Mukai M., Ikegame K., et al. Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. Clin Chim Acta 2011, 412(Suppl. 3-4):253-257.
7. Nagasaka Y., Fujii S., Yaga K., Matsumura S., Kaneko T. Clinical application of measuring serum fructosamine as an index of glycemic control in diabetic patients. Bull Yamaguchi Med Sch 1988, 35(3-4):59-62.
8. Baker J., Reid I., Holdaway I. Serum fructosamine in patients with diabetes mellitus. N Z Med J 1985, 98(782):532-535.
9. Hindle E.J., Rostron G.M., Clark S.A., Gatt J.A. Serum fructosamine and glycated haemoglobin measurements in diabetic control. Arch Dis Child 1986, 61(2):113-117.
10. Islam N., Akhter J., Kayani N., Khan M.A. Fructosamine: an alternative assessment of past glycaemic control in developing countries. J Pak Med Assoc 1993, 43(11):238-240.
11. World Health Organization Sickle cell anaemia: report by the secretariat 2006, World Health Organization, Geneva.
12. Kengne A.P., Kaze F.F., Dzudie A., Awah P.K., Ngu K.B. HIV/AIDS occurrence in the main university teaching hospital in Cameroon: audit of the 2001 activities of the service of internal medicine. J Int Assoc Physicians AIDS Care (Chic) 2007, 6(Mar (1)):61-65.
13. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16(1):31-41.
14. Box G.E.P., Cox D.R. An analysis of transformations. J R Stat Soc Ser B (Methodol) 1964, 26(2):211-252.
15. Kent J.T., Tyler D.E., Vardi Y. A curious likelihood identity for the multivariate t-distribution. Commu Stat-Simul Comput 1994, 23(2):441-453.
16. Simmons D., Clover G., Hopet C. Ethnic differences in diabetic retinopathy. Diabet Med 2007, 24:1093-1098.
17. Baker J., Metcalf A.P., Scragg R. Fructosamine concentrations in general population of Kawerau. Diabetes Care 1988, 11:239-245.
18. Brand Miller J.C. Importance of glycemic index in diabetes. Am J Clin Nutr 1994, 59:747-752.
19. Goodyear L.J., Kahn B.B. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998, 49:235-261.
20. Seidell J.C., Oosterlee A., Deurenberg P., Hautvast J.G.A.J., Ruijs J.H.J. Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age. Eur J Clin Nutr 1988, 42:805-815.
21. Misciagna G., Logroscino G., De Michele G., Cisternino A.M., Guerra V., Freudenheim J.L. Fructosamine, glycated hemoglobin, and dietary carbohydrates. Clin Chim Acta 2004, 340(1-2):139-147.
22. Jenkins D.J.A., Wolever T.M.S., Collier G.R., et al. Metabolic effects of a low-glycemic-index diet. Am J Clin Nutr 1987, (46):968-975.
23. Ryle A.J., Davie S.J., Gould B.J., Yudkin J.S. A study of the effect of diet on glycosylated haemoglobin and albumin levels and glucose tolerance in normal subjects. Diabetes Med 1990, 7:865-870.
24. Broussolle C., Tricot F., Garcia I., Orgiazzi J., Revol A. Evaluation of the fructosamine test in obesity: consequences for the assessment of past glycemic control in diabetes. Clin Biochem 1991, 24:203-209.
25. Skrha J., Svacina S. Serum fructosamine and obesity. Clin Chem 1991, 37:2020-2021.
26. Ardawi M.S.M., Nasratb H.A.N., Bahnassy A.A. Fructosamine in Obese normal subjects and type 2 diabetes. Diabetic Med 1994, 11:50-56.
27. Woo J., Cockram C., Lau E., Chan A., Swaminathan R. Influence of obesity on plasma fructosamine concentration. Clin Chem 1992, 38(11):2190-2192.
28. Perry H.M., Morley J.E., Miller D.K. Serum fructosamine and obesity. Diabetes Care 1999, 22:1596-1597.
29. Mosca A., Carenini A., Zoppi F., Carpinelli A., Banfi G., Ceriotti F., et al. Plasma protein glycation as measured by fructosamine assay. Clin Chem 1987, 33(7):1141-1146.
30. McLorg P.A. Lack of age-related increase in average glycemia in a non-Westernized sample of rural Yucatec Maya females. Am J Phys Anthropol 2005, 126(1):111-121.
31. Negoro H., Morley J.E., Rosenthal M.J. Utility of serum fructosamine as a measure of glycemia in young and old diabetic and non-diabetic subjects. Am J Med 1988, 85(3):360-364.
32. Boulanger E., Dequiedt P., Wautier J-L. Les produits de glycation avancée (AGE): de nouvelles toxines?. Nephron 2002, 23(7):349-357.